Chrome Extension
WeChat Mini Program
Use on ChatGLM

P-392 A Phase 1 Trial of 225Actinium-Dotadaratumumab in Patients with Daratumumab-Refractory Multiple Myeloma: Results from First Cohorts

Clinical Lymphoma Myeloma and Leukemia(2024)

Cited 0|Views0
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined